vs
Side-by-side financial comparison of F5, Inc. (FFIV) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
F5, Inc. is the larger business by last-quarter revenue ($811.7M vs $617.8M, roughly 1.3× Hims & Hers Health, Inc.). F5, Inc. runs the higher net margin — 18.2% vs 3.3%, a 14.9% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 11.0%). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 8.0%).
F5, Inc. is an American technology company specializing in application security, multi-cloud management, online fraud prevention, application delivery networking (ADN), application availability and performance, and network security, access, and authorization.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
FFIV vs HIMS — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $811.7M | $617.8M |
| Net Profit | $148.0M | $20.6M |
| Gross Margin | 81.4% | 71.9% |
| Operating Margin | 22.1% | 1.5% |
| Net Margin | 18.2% | 3.3% |
| Revenue YoY | 11.0% | 28.4% |
| Net Profit YoY | 1.5% | -20.8% |
| EPS (diluted) | $2.58 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $811.7M | — | ||
| Q4 25 | $822.5M | $617.8M | ||
| Q3 25 | $810.1M | $599.0M | ||
| Q2 25 | $780.4M | $544.8M | ||
| Q1 25 | $731.1M | $586.0M | ||
| Q4 24 | $766.5M | $481.1M | ||
| Q3 24 | $746.7M | $401.6M | ||
| Q2 24 | $695.5M | $315.6M |
| Q1 26 | $148.0M | — | ||
| Q4 25 | $180.1M | $20.6M | ||
| Q3 25 | $190.5M | $15.8M | ||
| Q2 25 | $189.9M | $42.5M | ||
| Q1 25 | $145.5M | $49.5M | ||
| Q4 24 | $166.4M | $26.0M | ||
| Q3 24 | $165.3M | $75.6M | ||
| Q2 24 | $144.1M | $13.3M |
| Q1 26 | 81.4% | — | ||
| Q4 25 | 81.5% | 71.9% | ||
| Q3 25 | 82.2% | 73.8% | ||
| Q2 25 | 81.0% | 76.4% | ||
| Q1 25 | 80.7% | 73.5% | ||
| Q4 24 | 81.7% | 76.8% | ||
| Q3 24 | 80.8% | 79.2% | ||
| Q2 24 | 80.4% | 81.3% |
| Q1 26 | 22.1% | — | ||
| Q4 25 | 26.0% | 1.5% | ||
| Q3 25 | 25.4% | 2.0% | ||
| Q2 25 | 25.2% | 4.9% | ||
| Q1 25 | 21.7% | 9.9% | ||
| Q4 24 | 26.8% | 3.9% | ||
| Q3 24 | 25.6% | 5.6% | ||
| Q2 24 | 23.4% | 3.5% |
| Q1 26 | 18.2% | — | ||
| Q4 25 | 21.9% | 3.3% | ||
| Q3 25 | 23.5% | 2.6% | ||
| Q2 25 | 24.3% | 7.8% | ||
| Q1 25 | 19.9% | 8.4% | ||
| Q4 24 | 21.7% | 5.4% | ||
| Q3 24 | 22.1% | 18.8% | ||
| Q2 24 | 20.7% | 4.2% |
| Q1 26 | $2.58 | — | ||
| Q4 25 | $3.10 | $0.08 | ||
| Q3 25 | $3.25 | $0.06 | ||
| Q2 25 | $3.25 | $0.17 | ||
| Q1 25 | $2.48 | $0.20 | ||
| Q4 24 | $2.82 | $0.10 | ||
| Q3 24 | $2.79 | $0.32 | ||
| Q2 24 | $2.44 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $228.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.6B | $540.9M |
| Total Assets | $6.5B | $2.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.2B | $228.6M | ||
| Q3 25 | $1.3B | $345.8M | ||
| Q2 25 | $1.4B | $1.1B | ||
| Q1 25 | $1.3B | $273.7M | ||
| Q4 24 | $1.2B | $220.6M | ||
| Q3 24 | $1.1B | $165.5M | ||
| Q2 24 | $935.6M | $129.3M |
| Q1 26 | $3.6B | — | ||
| Q4 25 | $3.5B | $540.9M | ||
| Q3 25 | $3.6B | $581.0M | ||
| Q2 25 | $3.5B | $562.7M | ||
| Q1 25 | $3.3B | $549.3M | ||
| Q4 24 | $3.2B | $476.7M | ||
| Q3 24 | $3.1B | $440.1M | ||
| Q2 24 | $3.0B | $362.0M |
| Q1 26 | $6.5B | — | ||
| Q4 25 | $6.3B | $2.2B | ||
| Q3 25 | $6.3B | $2.2B | ||
| Q2 25 | $6.1B | $1.9B | ||
| Q1 25 | $5.9B | $891.7M | ||
| Q4 24 | $5.9B | $707.5M | ||
| Q3 24 | $5.6B | $602.3M | ||
| Q2 24 | $5.4B | $480.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $525.1M | $61.3M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -0.4% |
| Capex IntensityCapex / Revenue | — | 10.3% |
| Cash ConversionOCF / Net Profit | 3.55× | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | — | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $525.1M | — | ||
| Q4 25 | $159.2M | $61.3M | ||
| Q3 25 | $208.1M | $148.7M | ||
| Q2 25 | $282.2M | $-19.1M | ||
| Q1 25 | $256.6M | $109.1M | ||
| Q4 24 | $202.8M | $86.4M | ||
| Q3 24 | $246.5M | $85.3M | ||
| Q2 24 | $159.0M | $53.6M |
| Q1 26 | — | — | ||
| Q4 25 | $149.5M | $-2.5M | ||
| Q3 25 | $191.9M | $79.3M | ||
| Q2 25 | $273.7M | $-69.5M | ||
| Q1 25 | $246.1M | $50.1M | ||
| Q4 24 | $194.7M | $59.5M | ||
| Q3 24 | $240.4M | $79.4M | ||
| Q2 24 | $153.1M | $47.6M |
| Q1 26 | — | — | ||
| Q4 25 | 18.2% | -0.4% | ||
| Q3 25 | 23.7% | 13.2% | ||
| Q2 25 | 35.1% | -12.8% | ||
| Q1 25 | 33.7% | 8.5% | ||
| Q4 24 | 25.4% | 12.4% | ||
| Q3 24 | 32.2% | 19.8% | ||
| Q2 24 | 22.0% | 15.1% |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 10.3% | ||
| Q3 25 | 2.0% | 11.6% | ||
| Q2 25 | 1.1% | 9.3% | ||
| Q1 25 | 1.4% | 10.1% | ||
| Q4 24 | 1.1% | 5.6% | ||
| Q3 24 | 0.8% | 1.5% | ||
| Q2 24 | 0.8% | 1.9% |
| Q1 26 | 3.55× | — | ||
| Q4 25 | 0.88× | 2.98× | ||
| Q3 25 | 1.09× | 9.43× | ||
| Q2 25 | 1.49× | -0.45× | ||
| Q1 25 | 1.76× | 2.20× | ||
| Q4 24 | 1.22× | 3.32× | ||
| Q3 24 | 1.49× | 1.13× | ||
| Q2 24 | 1.10× | 4.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
